Northern Trust’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-312,575
| Closed | -$4.68M | – | 4255 |
|
|
2016
Q2 | $4.68M | Sell |
312,575
-15,167
| -5% | -$195K | ﹤0.01% | 2515 |
|
|
2016
Q1 | $3.99M | Sell |
327,742
-44,123
| -12% | -$619K | ﹤0.01% | 2546 |
|
|
2015
Q4 | $5.92M | Buy |
371,865
+13,032
| +4% | +$205K | ﹤0.01% | 2361 |
|
|
2015
Q3 | $5.5M | Buy |
358,833
+52,834
| +17% | +$1.14M | ﹤0.01% | 2383 |
|
|
2015
Q2 | $7.44M | Buy |
305,999
+55,989
| +22% | +$1.34M | ﹤0.01% | 2262 |
|
|
2015
Q1 | $5.81M | Buy |
250,010
+3,542
| +1% | +$93.7K | ﹤0.01% | 2418 |
|
|
2014
Q4 | $6.19M | Sell |
246,468
-8,565
| -3% | -$251K | ﹤0.01% | 2367 |
|
|
2014
Q3 | $7.93M | Buy |
255,033
+22,606
| +10% | +$612K | ﹤0.01% | 2196 |
|
|
2014
Q2 | $6.01M | Sell |
232,427
-22,110
| -9% | -$491K | ﹤0.01% | 2391 |
|
|
2014
Q1 | $5.95M | Sell |
254,537
-21,226
| -8% | -$464K | ﹤0.01% | 2447 |
|
|
2013
Q4 | $7M | Buy |
275,763
+34,354
| +14% | +$776K | ﹤0.01% | 2320 |
|
|
2013
Q3 | $4.92M | Buy |
241,409
+76,024
| +46% | +$1.69M | ﹤0.01% | 2515 |
|
|
2013
Q2 | $3.47M | Buy |
+165,385
| New | +$2.96M | ﹤0.01% | 2648 |
|
Northern Trust's SGNT Position: Q3 2016 in Review
Northern Trust sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 312,575 shares — an estimated $4.68M sold.
Northern Trust first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $7.93M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.
- Northern Trust reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
- Northern Trust sold 312,575 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $4.68M.
- Northern Trust first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
- Northern Trust's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $7.93M in Q3 2014.
- 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.
Based on Northern Trust's 13F filing for Q3 2016, filed 10 Nov 2016.